TD Cowen Maintains Buy on CME Group, Raises Price Target to $300
TD Cowen analyst Bill Katz maintains CME Group (NASDAQ:CME) with a Buy and raises the price target from $292 to $300.
Stocks · News reference
UBS Maintains Neutral on CME Group, Raises Price Target to $270
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $260 to $270.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
CME Group Withdraws Its Filing To Introduce 24/7 10-Barrel Crude Oil Contract
CME Group Plans To Suspend Launch Of New 10-Barrel Crude Oil Futures Contract
Today, CME Group provided the following statement about its plans to suspend launch of a new 10-Barrel Crude Oil futures contract:"Providing efficient, regulated markets that allow our clients to cost-effectively